Cdk1 and BRCA1 target γ-tubulin to microtubule domains

被引:11
|
作者
Hubert, Thomas [2 ]
Vandekerckhove, Joel [2 ]
Gettemans, Jan [1 ,2 ]
机构
[1] Univ Ghent, VIB, Dept Med Prot Res, Fac Med & Hlth Sci, B-9000 Ghent, Belgium
[2] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium
关键词
Cdk1; BRCA1; gamma-Tubulin; Microtubule; DNA damage response; RNA-POLYMERASE-II; DNA-DAMAGE; BRCA1-DEPENDENT UBIQUITINATION; MAMMALIAN-CELLS; RING COMPLEX; C-MYC; NUCLEATION; LOCALIZATION; CHECKPOINT; BINDING;
D O I
10.1016/j.bbrc.2011.09.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA damage is a critical event that requires an appropriate cellular response. This is mediated by checkpoint proteins such as Cdk1 that controls S/G2 and G2/M transition. Cdk1 is required for BRCA1 transport to DNA damage sites inside the nucleus where BRCA1 functions as a scaffold to initiate a signaling cascade. BRCA1 is a multifunctional protein that also ubiquitinates gamma-tubulin and, consequently, inhibits microtubule nucleation at the centrosome. Here, we report that gamma-tubulin also localizes at confined areas in the microtubule network. Nocodazole-mediated microtubule depolymeration results in disappearance of this gamma-tubulin fraction, while microtubule stabilization by taxol preserves this structure. Surprisingly, overexpression of Cdk1 or BRCA1 greatly expands the gamma-tubulin coating of microtubules, suggesting that the microtubule-bound gamma-tubulin is involved in DNA damage response. This is in accordance with numerous reports of microtubule-associated DNA damage proteins, such as p53, that are transported to the nucleus when DNA damage occurs. gamma-Tubulin itself has been reported to form complexes with DNA repair proteins in the nucleus. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [41] LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers
    Martires, Lauren Catherine M.
    Ahronian, Leanne G.
    Pratt, Charlotte B.
    Das, Nikitha M.
    Zhang, Xiaobin
    Whittington, Douglas A.
    Zhang, Hongxiang
    Shen, Binzhang
    Come, Jon
    McCarren, Patrick
    Liu, Mu-Sen
    Min, Chengyin
    Feng, Tianshu
    Jahic, Haris
    Ali, Janid A.
    Aird, Daniel R.
    Li, Fang
    Andersen, Jannik N.
    Huang, Alan
    Mallender, William D.
    Nicholson, Hilary E.
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (04) : 618 - 627
  • [42] Characterization of CDK9/BRCA1 complex in DNA damage response
    Nepomuceno, Thales
    Fernandes, Vanessa
    Gomes, Thiago
    De Gregoris, Giuliana
    Carvalho, Renato
    Kurtz, Guilherme
    Monteiro, Alvaro
    Carvalho, Marcelo Alex
    CANCER RESEARCH, 2015, 75
  • [43] Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis
    Ekblad, CMS
    Friedler, A
    Veprintsev, D
    Weinberg, RL
    Itzhaki, LS
    PROTEIN SCIENCE, 2004, 13 (03) : 617 - 625
  • [44] Cohesin and Cdk1: an anaphase barricade
    Jones, Keith T.
    NATURE CELL BIOLOGY, 2010, 12 (02) : 106 - U14
  • [45] BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
    Clark-Knowles, Katherine V.
    O'Brien, Anna M.
    Weberpals, Johanne I.
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [46] Not all roads lead to Cdk1
    Branzei, Dana
    Ciliberto, Andrea
    CELL CYCLE, 2017, 16 (05) : 395 - 396
  • [47] BRCA1 recruitment to damaged DNA sites is dependent on CDK9
    Nepomuceno, Thales C.
    Fernandes, Vanessa C.
    Gomes, Thiago T.
    Carvalho, Renato S.
    Suarez-Kurtz, Guilherme
    Monteiro, Alvaro N.
    Carvalho, Marcelo A.
    CELL CYCLE, 2017, 16 (07) : 665 - 672
  • [48] BRCA1 and ER
    Rosen, EM
    Fan, S
    Ma, Y
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S4 - S4
  • [49] BRCA1 polymorphisms
    Campbell, IG
    Schroff, R
    Englefield, P
    Eccles, DM
    BRITISH JOURNAL OF CANCER, 1997, 75 (12) : 1854 - 1855
  • [50] REGULATION OF BRCA1
    BROWN, MA
    NICOLAI, H
    XU, CF
    GRIFFITHS, BL
    JONES, KA
    SOLOMON, E
    HOSKING, L
    TROWSDALE, J
    BLACK, DM
    MCFARLANE, R
    NATURE, 1994, 372 (6508) : 733 - 733